One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention The T-TIME Randomized Trial

Annette M. Maznyczka, MBChB (Hons); Peter J. McCartney, MBChB; Hany Eteiba, MD; John P. Greenwood, PhD; Douglas F. Muir, MBChB; Saqib Chowdhary, PhD; Anthony H. Gershlick, MBBS; Clare Appleby, PhD; James M. Cotton, MD; Andrew Wragg, PhD; Nick Curzen, PhD; Keith G. Oldroyd, MD (Hons); Mitchell Lindsay, MD; Margaret McEntegart, PhD; J. Paul Rocchiccioli, MD; Aadil Shaukat, MBBS; Richard Good, MD; Stuart Watkins, MD; Keith Robertson, PhD; Christopher Malkin, MD; Lynn Martin, BN; Lynsey Gillespie, PhD; Robin A. Weir, MD; Thomas J. Ford, MBChB; Mark C. Petrie, MBChB; Aengus Murphy, MD; Colin J. Petrie, PhD; Nitish Ramparsad, MSc; Kirsty Wetherall, BSc; Keith A. Fox, MBChB; Ian Ford, PhD; Alex McConnachie, PhD; Colin Berry, PhD; for the T-TIME Group